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PURPOSE. This study investigated multifocal pupillographic objective perimetry (mfPOP)
stimuli that target the intrinsic photosensitivity of melanopsin retinal ganglion cells. The
diagnostic potential for glaucoma is compared between stimuli biased toward either cone
input to these cells or their melanopsin response.
METHODS. Nineteen glaucoma patients and 24 normal subjects were tested using mfPOP
stimulus protocols with either 33-ms yellow or 750-ms blue stimuli. Subjects’ color
discrimination was assessed using the Farnsworth 100-hue test. Pupillary responses were
measured, and mixed-effects regression was used to quantify results. Diagnostic accuracy was
assessed using receiver operating characteristic (ROC) analysis.
RESULTS. The mean reduction in moderate to severe glaucoma pupil responses using blue
mfPOP stimuli was larger but more variable than that of the shorter yellow stimuli (blue:
1.32 dB [t(40) ¼ 2.29; P ¼ 0.027]; yellow: 0.93 dB [t(40) ¼ 3.13; P ¼ 0.003]). Color
discrimination decreased significantly with age and glaucoma, with type III blue-yellow
anomalies dominating. ROC analysis revealed similar diagnostic accuracies (AUC for eyes
classified as moderate to severe; blue: 81.7%, yellow: 83.7). Slightly higher sensitivity and
specificity were obtained using blue stimuli in mild disease (AUCs blue: 71.1, cf. yellow: 67.7),
although this difference was not significant.
CONCLUSIONS. In moderate to severe glaucoma, diagnostic accuracy of yellow and blue was
similar, but blue stimuli showed limited ability to resolve scotomas. Blue mfPOP stimuli,
however, may have advantages over yellow in detecting early glaucoma.
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Accurate, fast, and objective measurement of visual fields iscritical to the assessment of disorders such as glaucoma.
With this goal in mind, various forms of pupillographic
perimetry have been attempted,1–3 some using multifocal
methods.4,5 We have designed multifocal pupil stimuli that
are both temporally and spatially sparse, based on techniques
originally developed for evoked potentials.6–8 This method,
known as multifocal pupillographic objective perimetry
(mfPOP), allows us to measure the mean amplitude of pupil
constrictions in response to numerous stimulus presentations
made in each of 44 visual field test-regions per eye. Our recent
mfPOP studies have produced promising results in detection of
glaucoma and other diseases9–16 and have taught us much
about the pupillary system.17–19
Increasing knowledge of the involvement of intrinsically
photosensitive retinal ganglion cells (ipRGCs) in pupillary
responses has encouraged development of novel color-variant
pupillographic methods. Outer retinal input to ipRGCs
comprises ‘‘ON’’ luminance signal from medium-wavelength–
sensitive (M-) and long-wavelength–sensitive (L-) cone photo-
receptors and, at lower luminances, rod photoreceptors; and
‘‘OFF’’ signal from short-wavelength–sensitive (S-) cones.20,21 In
addition, ipRGCs possess an intrinsic response due to the
photopigment melanopsin.22–24 This intrinsic component has a
peak sensitivity of 482 nm and has much slower response
dynamics than cone-driven responses.25,26 Techniques devel-
oped initially by Kardon et al.25 and Park et al.27 use these
characteristics to preferentially target inner (rod/cone) or outer
(RGC) functions using red or blue full-field stimuli of suitable
intensities.
Application of these full-field methods in glaucoma has
relied largely on the measurement of the postillumination pupil
response (PIPR) to dark-adapted central-field stimulation.28,29
This sustained response component, which occurs following
the peak of constrictions, is attributed largely to melanopsin,
because its spectral sensitivity and temporal characteristics
closely match those of ipRGCs’ intrinsic response.25,26 McDou-
gal and Gamlin26 showed that once this melanopsin response is
activated, shunting of outer retinal signal produces ‘‘winner-
takes-all’’ behavior in the intrinsic response of these cells.
Responses to stimuli bright enough to result in a pupil diameter
of approximately 3 mm were found to be dominated by
melanopsin; for short duration stimuli, these measurements
incorporated early response components including the peak of
the response.26 This means that under conditions which elicit a
low-level but continuous melanopsin response such as our
mfPOP protocols, the peak amplitudes of constrictions due to
light increments from this baseline level are also likely
dominated by melanopsin. It seems plausible therefore, by
presenting blue stimuli on a photopic background, to use
mfPOP to elicit responses with a substantial melanopsin
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component and enable topographic assessment of the intrinsic
ipRGC response.
The mfPOP test protocols currently under development use
yellow stimuli,10,12 which minimizes any confounding effects
of lens brunescence30–33 or variations in macular pigment
density.34,35 These transient (33-ms) yellow stimuli favor the
excitatory extrinsic input of M- and L-cones to ipRGCs12; M-
and L-cones also contribute to pupillary responses via cortical
projections to the pretectum originating in midget and parasol
ganglion cells.10,36–38 The targeting of ipRGCs through their
intrinsic melanopsin response and minimization of midget and
parasol ganglion cell involvement, however, may confer
benefits in glaucoma assessment due to the sparse distribution
and limited spatial redundancy of these melanopsin-containing
cells.39 This study therefore compares the response character-
istics and diagnostic utility for glaucoma of a yellow stimulus
protocol using transient stimuli, with a protocol using blue
stimuli of long duration designed to target the intrinsic
component of the ipRGC response.
METHODS
This study consisted of two parts. The first part was a
preliminary experiment to assess the characteristics of pupil
responses to 750-ms red and blue mfPOP stimuli at four
luminance levels, to determine whether the results for blue
stimuli matched expectations from published studies for
melanopsin-driven responses. The main experiment compared
responses to 750-ms blue mfPOP stimuli with responses to our
standard 33-ms yellow in glaucomatous and normal eyes.
Subjects
Four normal subjects participated in the preliminary experi-
ment (Table 1). Their visual acuity was checked and visual
fields assessed using Humphrey FDT C-20 full threshold
perimetry (Carl Zeiss Meditec, Inc., Dublin, CA, USA).
Exclusion criteria are outlined below.
In the main experiment, 43 subjects were tested with blue
and yellow variants of mfPOP. Diagnostic status was confirmed
using Humphrey (HFA II) achromatic SITA-fast perimetry,
Matrix 24-2 perimetry, and Stratus OCT (all from Carl Zeiss
Meditec, Inc.), fundus photography, slit-lamp biomicroscopy,
and applanation tonometry. Color vision was assessed using
the Farnsworth 100-hue test (F100; Luneau Ophthalmologie,
Chartres, France). One putatively normal subject’s data were
excluded from analysis due to a F100 result exceeding the 95th
percentile of published norms.40 Final study group character-
istics are shown in Table 1 and Supplementary Table S1. Both
eyes of each subject were tested concurrently (n ¼ 86 visual
fields). Informed written consent was given by all participants
after the nature and possible consequences of the study were
explained, under ANU Human Experimentation Ethics Com-
mittee approval 238/04. All research adhered to the tenets of
the Declaration of Helsinki.
Glaucoma subjects were recruited from the Canberra Eye
Hospital and were required to have a diagnosis of open-angle
glaucoma with evidence of glaucomatous scotomas in at least
one eye (four subjects had normotensive glaucoma). Eyes of
glaucoma subjects were classified based on HFA mean
deviation (MD) as follows: moderate to severe glaucoma was
defined as MD less than6 dB (13 eyes); mild glaucoma as MD
equal to or greater than 6 dB (22 eyes); and ND denoted no
apparent field defects (3 fellow eyes). Normal subjects,
recruited from local optometric practices or by word of
mouth, were required to have no detectable glaucomatous
abnormalities, open angles, discs within normal limits, and
intraocular pressure of <21 mm Hg. Clinical characteristics of
subjects are provided in Supplementary Table S1.
Exclusion criteria for all subjects in both experiments
included evidence of other ocular pathology or previous ocular
surgery (argon or selective laser trabeculoplasty excepted in
patients), refractive errors greater than 66 diopters or more
than 2 diopters of cylinder, or systemic disease or medication
that might impair vision or pupillary responses. Subjects were
requested to not consume caffeine or alcohol for 1 hour before
testing.
Multifocal Infrared Pupillography
Presentation of mfPOP stimuli and monitoring of pupil diameter
were carried out using a prototype of the US Food and Drug
Administration–approved nuCoria Field Analyzer (nuCoria Pty.
Ltd., Acton, Australia). This tabletop device uses concurrent,
dichoptic presentation of temporally and spatially sparse
multifocal stimuli at 60 frames/s.9,11,12 Infrared light was used
to illuminate subjects’ pupils and their responses were
monitored by separate video cameras at 30 frames/s/eye. During
testing, subjects fixated on a small cross in the center of the
viewing field. Stimuli were presented at optical infinity to
minimize accommodative responses. Binocular fusion of the
two images was aided by large crosshairs and the low-contrast
(less than 60.1) radial sinusoidal variation of the stimulus
background (Fig. 1B). Gaze was monitored online, and data from
TABLE 1. Subject Group Characteristics, Plus Temporal and Luminance Characteristics of the Stimulus Protocols for the Main and Preliminary
Experiments
Stimulus Characteristics Preliminary Experiment Main Experiment
Subjects, n, mean 6 SD age, y Normal: 4 (2 males), 48.3 6 10.4 Glaucoma: 19 (10 males), 64.1 6 9.8
Normal: 24 (10 males), 59.8 6 7.3 y
Color Blue Blue Blue Blue Red Red Red Red Blue Yellow
Luminance, cd/m2 45 55 65 75* 45 55 65 75 75* 150†
Duration, ms 750 750 750 750 750 750 750 750 750 33
Mean interval between presentations/region, s 32 32 32 32 32 32 32 32 32 4
Average number of stimuli shown in each test-region 15 15 15 15 15 15 15 15 15 60
Recording duration, min 8 8 8 8 8 8 8 8 8 4
Experimental protocols differed in color, stimulus luminance and duration, presentation rate, and recording duration. Stimuli were presented on
a photopic background the same color as the stimuli but with a mean luminance of 10 cd/m2 (Fig. 1B). For details of the stimulus spectra, CIE
coordinates and relative cone activations refer to Figures 1D, 1E, 1F.
* Protocols are identical.
† Luminance values ranged between 67 and 150 cd/m2 depending on visual field location (Fig. 1C).
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blinks and fixation losses were deleted. The mfPOP method can
tolerate up to 15% data loss before a given 30-second segment
must be repeated. Corrective lenses compensated for refractive
errors to within 1.5 diopters; the stimuli contained no spatial
frequencies above 2 cyc/deg, making them tolerant of this
degree of misrefraction.41
Stimuli
The stimulus layout used in both experiments extended 6308
from fixation and consisted of 44 visual field test-regions
arranged in an overlapping dartboard configuration (Fig. 1A).11
The two experimental conditions (stimulus protocols) of the
main experiment used either transient 33-ms stimuli consisting
FIGURE 1. Stimulus color and luminance characteristics. (A) Left-eye–equivalent test-region map for the luminance-balanced yellow stimulus
protocol of the main experiment (shown in grayscale). The outer, median, and central rings of regions are shown at left, intermediate rings at right.
These two maps, overlaid in the manner shown at center, result in a 44-region-per-eye layout. This left-equivalent map was inverted left-to-right for
the right eye so that any temporonasal variations in luminance were maintained. (B) A single frame of the yellow stimulus protocol as viewed by a
subject (shown in grayscale). The radial background for each protocol was the same color as the stimulus in each case but was displayed at a lower
mean luminance of 10 cd/m2. Temporal and spatial sparseness of the stimulus presentation is apparent in the small proportion and diffuse spacing
of the test-regions active in this frame. The dichoptic presentation of these stimuli means that some of these regions are viewed by one eye and the
remainder by the other eye, in a cyclopean view. Thus, the two separate images are fused by the subject to form the percept shown. (C) Test-region
luminances for the protocols of the main experiment. The yellow protocol used luminance-balanced stimuli, and therefore luminances varied
among regions (Maddess T, et al. IOVS 2009;50:ARVO E-Abstract 5281; Kolic M, et al. IOVS 2009;50:ARVO E-Abstract 5280). This subtle variation can
be seen in (A); compare the luminance of the brightest region in the inner ring of the right-hand figure (150 cd/m2) with that of the dimmest region
immediately above the midline at the far left of the left-hand figure (67 cd/m2). All other protocols used stimuli presented at a single luminance
level, as in the 75 cd/m2 test-regions of the blue protocol shown here. (D) Color spectra for each of the stimuli. (E) CIE coordinates with test-region
values plotted in black and backgrounds in gray. (F) Proportional cone activations for the stimuli. (G) Mean baseline pupil diameters across all
subjects (filled squares) for the protocols used in the preliminary experiment and log photon/cm2/s equivalents (filled circles) for each stimulus
luminance and color. Note that the 75 cd/m2 blue condition is the same as that used in the main experiment. Values for these are reported in
Supplementary Table S2.
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mainly of medium- and long-wavelength light: the M-þ L-cone-
biased ‘‘yellow’’ protocol, or longer duration 750-ms stimuli
consisting mainly of shorter wavelength light: the melanopsin-
biased ‘‘blue’’ protocol (see details below). The integration
time of melanopsin is long: blue stimuli much shorter than this
may exclude the intrinsic response.25,26 Stimuli in the
preliminary experiment had temporal characteristics identical
to those of the blue protocol (duration: 750 ms) but used red
and blue stimuli presented at four different luminance levels
(Table 1).
Each stimulus sequence was separated into segments lasting
30 seconds; the yellow protocol contained 8 of these
segments, giving a total recording duration of 4 minutes (Table
1). The blue and red protocols, due to their much longer
stimuli and lower presentation rate, consisted of 16 segments
with a total recording duration of 8 minutes. Stimuli in all
protocols were presented on a photopic background (mean
luminance of 10 cd/m2), the same color as the stimuli. The
presence of some spectral components over 500 nm in the
blue background should serve to maintain levels of the 11-cis
melanopsin isomer and enable continuous ipRGC firing.42 The
CIE x-y coordinates for yellow protocol test-regions were 0.377
and 0.464, respectively, and 0.408 and 0.515, respectively, for
the background (Fig. 1D). This protocol used ‘‘partially
luminance-balanced’’ stimuli to minimize the effects of
response saturation12; therefore, the luminance of test-regions
ranged between 67 and 150 cd/m2, depending on their
location in the visual field10,14 (Fig. 1C). Balancing results in
reduced topographic variation in response amplitudes and
improves diagnostic power for glaucoma (Maddess T, et al.
IOVS 2009;50:ARVO E-Abstract 5281). The luminance of all
test-regions in the blue protocol was 75 cd/m2. CIE x-y
coordinates of these regions were 0.145 and 0.113, respec-
tively, and 0.137 and 0.120, respectively, for the background
(Fig. 1E). Luminance-balanced stimuli were not used in this
protocol due to finding in the preliminary experiment that
response saturation was not present at this level of blue
illumination (Fig. 2). Proportional cone activations for the
color channels used in both experiments are shown in Figure
3. These were estimated using human cone sensitivity
functions43 and measured spectra at luminances of 75 cd/m2
for the nuCoria field analyzer red and blue channels and 108
cd/m2 for yellow.
Response Estimation
Signal processing was carried out using custom-designed
software developed using Matlab (release R2010b; MathWorks
Inc., Natick, MA, USA). Response waveforms for each test-
region were extracted from raw pupillary responses using
multiple linear regression as previously described.6,7,10 This
method provided a set of 176 response estimates (waveforms)
for each subject and protocol: both direct and consensual
responses for left and right eyes for each of the 44 test-regions.
Thus, for each region, these response estimates are effectively
the mean of the responses to either 60 (yellow protocol) or 15
FIGURE 2. Mean responses from a preliminary experiment comparing red and blue stimulus protocols. (A) Average response waveforms for blue
and red protocols. (B) Mean amplitudes of pupillary responses to blue and red mfPOP protocols were plotted against stimulus luminances (45, 55,
65, or 75 cd/m2) of each set of protocols. The red stimuli produced functions (dashed lines) that saturated as luminance increased. In contrast, the
blue response waveform (solid line) demonstrated increasing gain with stimulus luminance and no evidence of saturation. (C) Mean waveforms are
scaled as proportions of peak constriction amplitudes. White headed arrows indicate the PIPR for each blue protocol: black- and open-headed
arrows show the positive components for red and blue protocols, respectively.
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(blue protocol) individual stimulus presentations to that
region. Pupil diameter measurements were normalized to a
mean pupil diameter of 3500 lm as in previous studies,
providing constriction amplitudes that are relative to that
standard diameter.9,11,12,19
Analysis
Sources of variation in the F100 total error scores (TESs) of
glaucoma and normal subjects were quantified using multiple
linear regression. The effects of relevant study variables on
pupillary constriction amplitudes were calculated using a
mixed-effects model incorporating restricted maximum likeli-
hood estimation44 in R software (R Core Team 2013, Vienna,
Austria). The distribution of variance in response amplitudes
was stabilized initially using a generalized logarithmic trans-
form as described previously10,18; model outputs are therefore
reported in dB. Random effects were fitted for the nested
factors eye within subject, and the remaining variates fitted as
fixed effects.
Receiver operating characteristic (ROC) analysis, which
offsets the true positive rate of a method against its false
positive rate, was used to assess diagnostic performance.11,19
ROC curves and their area under the curve (AUC) values were
calculated for each protocol and severity classification. This
involved selecting responses for each test-region from the
pupil with the best signal-to-noise ratio (i.e., either the direct or
consensual response). Z-score deviations from average normal
responses were then calculated, incorporating a decibel offset
for sex, because mfPOP responses are typically smaller in
females.45 ROC curves were calculated using these z-scores for
the means of varying-sized subsets of the most deviating test-
regions of each eye, from the single worst-performing region
(n-worst ¼ 1), the mean of the 2 worst-performing regions (n-
worst¼ 2), to the mean of all 44 test-region deviations of each
field (n-worst ¼ 44).
RESULTS
Preliminary Experiment
Mean response waveforms and constriction amplitudes across
test-regions, eyes, and subjects are presented in Figure 2. Mean
amplitudes of red protocol responses were slightly larger than
those of blue (Figs. 2A, 2B). This is most likely due to the larger
baseline pupil diameters, and therefore higher retinal illumi-
nance, during testing with red protocols (Fig. 1D; Supplemen-
tary Table S2). Constriction amplitudes increased with
luminance in both blue and red protocols (Figs. 2A, 2B). Red
protocol amplitudes, however, plateaued at 65 cd/m2 and
above; in contrast, blue amplitudes accelerated at equivalent
luminances. In blue protocols, this marked increase in
amplitude was replicated in the PIPR and also in the decrease
of the positive dilation component. There was little evidence
of a PIPR in red protocols; the amplitude of the small
deflection that was present did not change. In contrast to
blue, higher luminance also increased the strength of the
positive component. The scaled responses plotted in Figure 2C
show that these patterns hold when taken as a proportion of
the overall constriction amplitude (Fig. 2C, white-headed
arrows indicate the increase in blue PIPR, and black- and
open-headed arrows highlight the opposing effects of in-
creased red and blue luminance on the positive response
component). In contrast to the responses to red stimuli, the
response waveforms and stimulus response function for blue
stimuli were consistent with substantial melanopsin involve-
ment.20,46
Main Experiment
F100 Color Discrimination. A possible confounding
factor for these experiments are color vision deficits from
various sources, so color vision was tested in all subjects. F100
TESs ranged from 4 to 169 in normal subjects and from 43 to
169 in patients. Multiple linear regression revealed significant
independent effects of both diagnosis and age on color
discrimination. The mean TES for normal subjects was 46.5,
increasing on average by 16.4 per 10-year increment in age
[t(40) ¼ 2.6; P ¼ 0.013]. Independent of this age effect,
patients’ scores averaged 33.2 higher than normal subjects
[t(40)¼ 3.1, P¼ 0.004]. Mean and median test results for each
group are shown in Figure 3, which indicates that the majority
of variation in these subjects is due to a tendency toward type
III tritan-like anomalies, this being more pronounced in
patients.
Pupillary Response Characteristics. Of the 1032 thirty-
second protocol segments presented to the subjects in this
study’s main experiment, only 4 segments needed to be
repeated due to the criterion lack of more than 15% of that
segment’s data. The mean pupillary constriction waveforms for
the two protocols differed slightly; the time course of
constrictions elicited by the blue protocol was substantially
longer, with evidence of a PIPR sustained component following
the peak of the response (Fig. 4A).
Pupillary response characteristics were assessed by stimulus
protocol, diagnostic status, age, sex, color discrimination, and
location of the test-region in the visual field. The yellow
protocol produced mean constriction amplitudes that were
significantly smaller than those of the blue (16.26  11.64 ¼
4.62 dB; t(7481) ¼ 104.3; P < 0.0001) (Table 2). Mean
baseline pupil diameters differed in a manner similar to those
in the preliminary experiment, with the longer wavelength
yellow protocol producing a larger diameter of 3.47 mm than
that of blue at 2.70 mm. The smaller responses obtained using
this yellow protocol are therefore most likely due to the short
FIGURE 3. Farnsworth 100-hue test (F100) error score characteristics
for normal and glaucoma subject groups of the main experiment (for
clarity, only the central area of the F100 plots are shown; standard F100
plots extend outwardly to error scores of 14). Median values are
represented by solid and dotted black lines (legend) and mean values
by the extent of the gray shaded areas. Note the tendency toward
blue-yellow type III (tritan-like) anomalies in both groups. The scores
of glaucoma subjects are significantly higher than those of normal
subjects (P < 0.05 [see Results, Main Experiment, F100 Color
Discrimination]).
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duration of the yellow stimuli. In both yellow and blue
protocols, the largest regional constriction amplitudes were
obtained to stimuli in the temporal field (Fig. 4B). Mean
constriction amplitudes of eyes with moderate to severe
glaucoma were significantly smaller than those of normal
subjects in both protocols: blue by1.32 dB [t(40)¼2.29; P¼
0.027], yellow by a smaller but more significant margin of
0.93 dB [t(40) ¼3.13; P ¼ 0.003] (Table 2). No significant
difference was observed between mild glaucoma and normal
subjects or for any other of the fitted variates.
Diagnostic Accuracy. ROC plots for the n-worst test-
regions that produced the highest AUC for each severity are
shown in Figure 5A. The diagnostic performance of the two
protocols was quite similar (Table 3). On inclusion of all
subject eyes (i.e., all severities) in the analysis, an overall AUC
value of 70.9% (65.6% SE, n-worst ¼ 41) was obtained using
the blue protocol, and 71.3% (65.9% SE, n-worst¼1) using the
yellow protocol. Both of the protocols were able to detect eyes
classified as severe (HFA MD less than 12 dB) with 100%
accuracy, and both produced AUCs of 79% for eyes classified as
moderate.
The two protocols differed, however, in the pattern of
which n-worst regions produced the highest AUCs. In
moderate to severe eyes, the accuracy of the yellow protocol
was highest when only each subject’s single most deviating
test-regions were included in the analysis. The blue protocol,
however, demonstrated increasing accuracy on inclusion of
larger numbers of these worst performing regions (Fig. 5B).
Thus, this protocol appeared to have lesser capacity than
yellow to detect localized damage in advanced disease, relying
instead on measures akin to the mean defect to derive
diagnostic power. In contrast, in eyes classified as mild, both
of the protocols were most accurate using just the single worst-
performing region. The blue protocol produced a slightly
higher AUC, but this value was not significantly different from
that produced by the yellow protocol.
DISCUSSION
The potential of mfPOP as an emerging diagnostic tool for
glaucoma is considerable, with its diagnostic accuracy compa-
rable to commonly used forms of perimetry.9,19 This study
FIGURE 4. (A) Averaged pupillary response waveforms showing the general form taken by responses to the two different stimulus protocols of the
main experiment (means for glaucoma and normal subjects computed across eyes, pupils, and visual field regions). The blue response waveforms
show a PIPR component in the redilation phase. (B) Constriction amplitude means by region from a mixed-effects model incorporating effects for
sex, eye, age, F100 TES, and diagnosis of subjects. Thus, these regional means represent the responses of left eyes of male subjects aged 60 with
normal vision and average color sensitivity, and are subject to modification by the effects reported in Table 2. All results are mapped as left-eye–
equivalent visual fields with the temporal field shown here on the left. Constriction amplitudes were largest in the temporal field in both blue and
yellow protocols.
TABLE 2. Fixed Effects of Study Variables From Linear Mixed-Effects Models for Blue and Yellow mfPOP Protocols
Blue Protocol Yellow Protocol
b, dB df t P b, dB df t P
Constant 16.259 3698 – – 11.639 3698 – –
DecadeRel60 0.157 39 0.55 0.5823 0.132 39 1.01 0.3175
Right eye 0.059 40 0.41 0.6871 0.031 40 0.26 0.7933
Female 0.164 39 0.37 0.7153 0.211 39 1.02 0.3140
Glaucoma, mild/ND* 0.005 40 0.01 0.9919 0.221 40 0.89 0.3793
Glaucoma, moderate/severe 1.318 40 2.29 0.0272 0.925 40 3.13 0.0033
F100 0.021 39 0.31 0.7590 0.056 39 1.80 0.0793
Additive effects (b) are relative to the y intercept or Constant, which describes the mean of constriction amplitudes across the 44 test-regions of
left eyes of male subjects aged 60 with normal vision and average color sensitivity. DecadeRel60 refers to an additive slope in dB/decade relative to
60 years. For the variable F100, 120 (the normative mean TES for a 60-year-old subject37) was subtracted from subjects’ total error scores in order to
maintain parity with DecadeRel60. The result was then divided by 10 to provide a more practical measure; therefore, the fitted values refer to the
additive effect of F100 increments of 10, relative to a TES of 120 on constriction amplitudes.
* Putatively normal eyes of glaucoma patients.
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aimed to determine whether improvements could be made to
methods currently being developed by targeting the intrinsic
component of the ipRGC response. Pupil perimetry using
single blue stimuli have been undertaken47,48; however, these
studies used dark-adapted subjects, so responses will have also
involved rod photoreceptors. The use of a photopic blue
adapting background in this experiment aimed to minimize rod
involvement and facilitate the observation of melanopsin
responses.
Preliminary Experiment and Melanopsin
Involvement
As well as being largely responsible for the PIPR, some results
suggest that melanopsin has a substantial influence on early
response components at luminance levels and durations similar
to those used in our main experiment (Fig. 1).20 Additionally, at
pupillary diameters equivalent to those achieved using blue
mfPOP (Supplementary Table S2), the spectral sensitivity of
these early response components appears to be dominated by
melanopsin.26 Therefore, the potential to obtain melanopsin-
influenced mfPOP responses exists; several characteristics of
the responses obtained to blue stimulation in these experi-
ments appear to confirm this.
The accelerating stimulus-response function shown in
Figure 2B and the differences between red and blue later
response components (Figs. 2A, 2C) are consistent with
observations of the progressive domination of pupil responses
by melanopsin at higher luminances.26 This contrasts with the
saturating stimulus-response functions we obtained previously
using yellow stimuli12 and which were also observed using red
stimuli in the preliminary experiment (Fig. 2B). The decrease
in the positive component of blue responses is consistent with
the greatly reduced b-wave seen in isolated melanopsin
responses to flash electroretinography in macaques20 and
lends strength to the assertion that melanopsin is involved in
these responses to 750-ms blue mfPOP stimuli. The congru-
ence between the changes in peak amplitude of constrictions
and both the PIPR and positive dilation component is highly
suggestive of a substantial melanopsin contribution to early
(i.e., response amplitudes), as well as later components. It
seems reasonable therefore to conclude that, although cone
photoreceptors have undoubtedly participated in responses to
the blue protocol of the main experiment as sources of both
excitatory and inhibitory input (Fig. 3, cone activations), pupil
constriction amplitudes in the blue protocol were also
substantially influenced by melanopsin.
Short-Wavelength Discrimination
Normal aging results in increases in absorption of shorter
wavelength light by the crystalline lens, observable as
FIGURE 5. (A) ROC curves for each level of functional defect for blue and yellow protocols (ND¼ putatively normal eyes of glaucoma subjects).
Precise AUC values, SE and n-worst values are reported in Table 3. (B) Estimation of ROC AUC values was carried out using varying numbers of the
regions having the greatest deviations from normal, described as n-worst. This plot shows the AUC values obtained using n-worst visual field
deviations ranging from n¼ 1 to 44 for both protocols, for the 13 eyes classified as moderate to severe. The yellow protocol achieved its highest
accuracy using only very few of these worst performing regions. The blue protocol, in contrast, improved in accuracy as more regions were
included in the analysis. This pattern reflects the overall trend for the blue and yellow protocols. Notice also that the AUC values for what is
essentially the mean defect (n-worst ¼ 44) also differ for blue and yellow stimuli.
TABLE 3. Percent ROC Area Under the Curve (AUC) and AUC Standard Error (SE) Values
Severity (n eyes)
Blue Protocol Yellow Protocol
AUC, % SE, % n-worst AUC, % SE, % n-worst
Moderate to severe (13) 81.7 6.1 42 83.7 7.4 1
Mild (22) 71.1 8.0 1 67.7 7.7 1
ND* (3) 47.2 13.4 44 59.0 11.5 37:38
ROC estimates were obtained using response amplitudes and the optimal number of n-worst deviations from normal from any position in the
visual field. Diagnostic accuracy using the yellow protocol was high when only a limited number of the worst performing regions were included in
the analysis (Fig. 5B). The blue protocol, however, displayed a tendency for accuracy to increase with the inclusion of more regions. This was
particularly apparent for eyes with moderate to severe defects.
* Putatively normal eyes of glaucoma patients.
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yellowing or brunescence,30–33 as well as changes in the
function of S-cone pathways.49 Evidence of this is seen in the
increase in F100 TESs with age and the reduced blue-yellow
discrimination illustrated in Figure 3. The antagonistic effect of
S-cone stimulation on the intrinsic and M- þ L-cone–derived
ipRGC response is postulated to arise in DB6 bipolar cells, the
major source of synaptic input to ipRGCs.50 This is proposed
to be due to S-cone ON inactivation of ionotropic glutamater-
gic ion channels, preferentially expressed at S-cone synapses,
leading to hyperpolarization of the DB6 cell. This would
counteract the depolarization caused by the M- þ L-cone
inactivation of metabotropic ion channels in these same cells
and reduce excitatory input to ipRGCs.51 The potential effect
of brunescence on ipRGC responses is therefore twofold: (1)
an overall reduction in the intrinsic melanopsin response; and
(2) an increased bipolar cell synaptic input due to a reduction
in antagonistic signal arising in S-cones. No significant
independent effect of age or color sensitivity was observed
in responses to the blue protocol (Table 2). A possible
explanation for this is that any effects of brunescence may
have counteracted each other (i.e., reduced melanopsin
responses balanced by reduced S-cone antagonism). Similarly,
age was not seen to significantly affect responses to the yellow
protocol (Table 2), perhaps spared by the longer wavelengths
of the stimuli. The alternative explanation, that brunescence
did not affect retinal function, is unlikely because age was
shown to have a significant effect on F100 error scores.
Abnormalities in blue-yellow discrimination also occur in
glaucoma, independent of the effects of aging or media
opacities,52–55 and probably account for the greater type III
color anomalies seen in patients (Fig. 4). This has been
attributed to selective RGC loss52; however, pressure-related
damage to S-cone bipolar cells has also been implicated.56
Reduced S-cone inhibitory input could potentially mask the
effects of RGC loss on pupillary constrictions by increasing
responses in the remaining functioning RGCs. This may
account for the greater variability in patients’ response
amplitudes to the blue protocol (Table 2).
Identification of Localized Dysfunction
The restriction of comparisons between normal and glaucoma
subjects to different sized subsets of n-worst regions can be
used as a measure of a test’s ability to identify localized areas of
dysfunction. Although much damage to retinal ganglion cells in
glaucoma is diffuse,57,58 localized scotomas are an obvious
feature. In severe eyes, reliance of the blue protocol on mean
deviations to achieve best diagnostic accuracy contrasts with
the yellow protocol, where the best results were obtained
using only the few worst performing test-regions, highlighting
its ability to detect highly diagnostic localized depressions in
sensitivity (Fig. 5B). Considering only the mean defect (i.e., n-
worst ¼ 44), diagnostic performance was quite different for
yellow and blue stimuli. If these protocols’ diagnostic
accuracies were comparable, they would be expected to
produce similar mean defect–related ROC values. This is
clearly not the case. Taken together, the larger mean reduction
in regional amplitudes for yellow and the very different
response patterns of the two protocols in eyes with established
scotomas (Fig. 5B) suggest that different physiology and
possibly even different neural pathways are involved.
Postreceptor retinal factors, such as differently sized RGC
receptive fields, are most likely not responsible; cone-mediated
receptive fields of ipRGCs are colocalized with their dendritic
arborization,21 and blue-yellow RGC receptive fields in
primates, although slightly larger than those of red-green
sensitive RGCs,59 are not different enough to account for this.
Forward scatter of light transmitted by the aging crystalline
lens, although more prevalent at shorter wavelengths,33,60,61 is
not likely to result in sufficient blurring of stimuli to render
scotomas invisible.60,62 Cortical input to the pupillary pathway
could potentially play a role,36 perhaps using a similar global
mechanism to the accommodative response to optical defo-
cus,63,64 although exactly how this would result in these
differences between blue and yellow is not clear.
CONCLUSIONS
This study’s aim was to determine the viability of mfPOP
stimuli that target the intrinsic melanopsin response of
ipRGCs. Little difference was observed between the overall
diagnostic accuracies of the blue and yellow stimuli, the
slightly higher ROC AUC of the blue protocol not being
significantly different from yellow. The blue protocol produced
much larger constriction amplitudes and signal-to-noise ratios
than the yellow protocol, without evidence of response
saturation. Yellow stimuli produced less variable reductions
in patients’ response amplitudes and had better sensitivity to
localized defects in established disease. In advanced disease,
the diagnostic value of the blue protocol appeared somewhat
prone to confounding factors related to aging and the disease
process; similar issues have previously been found to hamper
short-wavelength automated perimetry.65,66 Although this
melanopsin-targeted protocol did not appear to lend any
advantage in identification of later-stage glaucoma, it may have
potential in the detection and management of early disease or
possibly in other diseases in which sensitivity to short-
wavelength light is affected. The replication of this study
using a larger cohort would likely clarify the potential benefits
of blue mfPOP stimuli relative to those of yellow in early
glaucoma.
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